PDCD1 and cancer: In recent years, immunotherapy has become an increasingly promising therapeutic method for advanced UC, with immune checkpoint inhibitors being able to halt immune evasion of cancer cells by preventing programmed cell death protein 1 (PD-1) from binding to its ligand [6].